LifeMD, Inc. (NASDAQ:LFMD) CEO Sells $129,750.00 in Stock

LifeMD, Inc. (NASDAQ:LFMD) CEO Justin Schreiber sold 25,000 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $5.19, for a total value of $129,750.00. Following the transaction, the chief executive officer now owns 2,703,715 shares in the company, valued at $14,032,280.85. This represents a 0.92 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Justin Schreiber also recently made the following trade(s):

• On Monday, December 2nd, Justin Schreiber sold 25,000 shares of LifeMD stock. The stock was sold at an average price of $6.52, for a total value of $163,000.00.

LifeMD Stock Performance

NASDAQ LFMD opened at $5.10 on Thursday. LifeMD, Inc. has a 1-year low of $3.99 and a 1-year high of $12.88. The company has a 50 day moving average of $5.57 and a 200-day moving average of $5.55. The company has a current ratio of 0.83, a quick ratio of 0.78 and a debt-to-equity ratio of 10.83. The firm has a market cap of $220.89 million, a price-to-earnings ratio of -7.97 and a beta of 1.49.

Institutional Investors Weigh In On LifeMD

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. State Street Corp boosted its stake in LifeMD by 20.0% in the third quarter. State Street Corp now owns 1,155,495 shares of the company’s stock worth $6,055,000 after purchasing an additional 192,861 shares in the last quarter. Royce & Associates LP raised its holdings in shares of LifeMD by 14.6% in the third quarter. Royce & Associates LP now owns 901,041 shares of the company’s stock valued at $4,721,000 after buying an additional 114,710 shares during the last quarter. Los Angeles Capital Management LLC lifted its position in LifeMD by 852.6% during the 3rd quarter. Los Angeles Capital Management LLC now owns 121,585 shares of the company’s stock worth $637,000 after buying an additional 108,822 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in LifeMD by 63.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 234,583 shares of the company’s stock worth $1,609,000 after acquiring an additional 91,183 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in LifeMD by 11.4% in the 3rd quarter. Geode Capital Management LLC now owns 819,233 shares of the company’s stock valued at $4,293,000 after acquiring an additional 83,598 shares in the last quarter. 35.52% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts recently commented on LFMD shares. Lake Street Capital initiated coverage on LifeMD in a research report on Tuesday, December 10th. They issued a “buy” rating and a $12.00 target price for the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $15.00 target price on shares of LifeMD in a research report on Friday, September 20th. Mizuho began coverage on shares of LifeMD in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $7.00 price target for the company. HC Wainwright reaffirmed a “buy” rating and set a $12.00 price objective on shares of LifeMD in a report on Monday, November 11th. Finally, KeyCorp lowered their price objective on LifeMD from $10.00 to $7.00 and set an “overweight” rating on the stock in a research note on Wednesday. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $11.14.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.